Home » Topics » BioWorld Science

BioWorld Science
RSS

Galapagos NV presents new DDR inhibitors

July 13, 2022

Shanghai Visonpharma discloses new GTPase KRAS inhibitors

July 13, 2022

MJFF grant supports evaluation of EpicentRx's NLRP3 inflammasome inhibitor for Parkinson's

July 13, 2022

Beijing Innocare Medical Technology patents JAK inhibitors

July 13, 2022

Renovacor to advance AAV gene therapy program for arrhythmogenic cardiomyopathy

July 13, 2022

VesiVax Af3/9 vaccine protects against invasive pulmonary aspergillosis

July 13, 2022

LONP1 targeting sensitizes therapy-resistant tumor cells to sorafenib

July 13, 2022

Tenaya sets out rationale for targeting HDAC6 in heart failure

July 12, 2022

PARP/SIK2 inhibition shows potential for treating ovarian cancer and TNBC

July 12, 2022

iNtRON Biotechnology reports efficacy of CDL-200 against clinical isolates from CDI patients

July 12, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
XPC-837 restores network dysfunction in Dravet syndrome models
BioWorld Science
Researchers from Xenon Pharmaceuticals Inc. described the preclinical efficacy of XPC-837 in models of Dravet syndrome, a severe developmental and epileptic...